-
公开(公告)号:US20060281763A1
公开(公告)日:2006-12-14
申请号:US11390980
申请日:2006-03-27
申请人: Jonathan Axon , Sarvajit Chakravarty , Barry Hart , Glenn McEnroe , Alison Murphy , Karen Pontius , Peijue Sheng , Xiaojing Wang , Shanthi Yellapregada
发明人: Jonathan Axon , Sarvajit Chakravarty , Barry Hart , Glenn McEnroe , Alison Murphy , Karen Pontius , Peijue Sheng , Xiaojing Wang , Shanthi Yellapregada
IPC分类号: C07D403/14 , C07D403/02 , A61K31/506
CPC分类号: C07D401/12 , C07D401/14 , C07D405/14 , C07D413/14 , C07D495/04
摘要: Certain appropriately substituted forms of pyrimidine having a pyridylamine group at C-4 of the pyrimidine and an amide group on the pyridine ring are useful in the treatment of conditions associated with excessive TGFβ activity.
摘要翻译: 在嘧啶的C-4处具有吡啶基胺基的嘧啶的某些适当取代的形式和吡啶环上的酰胺基可用于治疗与过量TGFbeta活性相关的病症。
-
公开(公告)号:US20070066632A1
公开(公告)日:2007-03-22
申请号:US11391726
申请日:2006-03-27
IPC分类号: A61K31/519 , C07D487/02
CPC分类号: C07D471/04
摘要: Certain appropriately substituted fused bicyclic pyrimidine compounds having an amide-substituted pyridylamine group at C-4 of the pyrimidine ring are useful in the treatment of conditions associated with excessive TGFβ activity and certain viral disorders.
摘要翻译: 在嘧啶环的C-4具有酰胺取代的吡啶基胺基团的某些适当取代的稠合双环嘧啶化合物可用于治疗与过量TGFbeta活性和某些病毒性疾病相关的病症。
-
公开(公告)号:US07223766B2
公开(公告)日:2007-05-29
申请号:US10811428
申请日:2004-03-26
申请人: Sundeep Dugar , Sarvajit Chakravarty , Aurelia Conte , Jonathan Axon , Glenn McEnroe , Alison Murphy
发明人: Sundeep Dugar , Sarvajit Chakravarty , Aurelia Conte , Jonathan Axon , Glenn McEnroe , Alison Murphy
IPC分类号: A61K31/517 , C07D239/70
CPC分类号: C07D487/04 , A61K31/517 , C07D239/94 , C07D401/04 , C07D401/12 , C07D401/14 , C07D413/14 , C07D471/04 , C07D491/04 , C07D493/04 , C07D495/04 , C07D498/04
摘要: Compounds in which a pyrimidine nucleus is bridged at the 5 and 6 position and are further substituted at positions 2 and 4 with substituents comprising aromatic moieties are useful in treating subjects with rheumatoid arthritis ameliorated by inhibition of TGFβ activity.
摘要翻译: 其中嘧啶核在5和6位桥连并且在2和4位被含有芳族部分的取代基进一步取代的化合物可用于治疗通过抑制TGFbeta活性而改善的类风湿关节炎的受试者。
-
公开(公告)号:US20050004143A1
公开(公告)日:2005-01-06
申请号:US10811428
申请日:2004-03-26
申请人: Sundeep Dugar , Sarvajit Chakravarty , Aurelia Conte , Jonathan Axon , Glenn McEnroe , Alison Murphy
发明人: Sundeep Dugar , Sarvajit Chakravarty , Aurelia Conte , Jonathan Axon , Glenn McEnroe , Alison Murphy
IPC分类号: A61K31/517 , A61K31/519 , C07D239/94 , C07D401/12 , C07D487/02 , C07D487/04 , C07D491/02 , C07D491/04 , C07D495/04 , C07D498/02 , C07D498/04
CPC分类号: C07D487/04 , A61K31/517 , C07D239/94 , C07D401/04 , C07D401/12 , C07D401/14 , C07D413/14 , C07D471/04 , C07D491/04 , C07D493/04 , C07D495/04 , C07D498/04
摘要: Compounds in which a pyrimidine nucleus is bridged at the 5 and 6 position and are further substituted at positions 2 and 4 with substituents comprising aromatic moieties are useful in treating subjects with conditions ameliorated by inhibition of TGFβ activity.
摘要翻译: 其中嘧啶核在5和6位上桥连并且在2和4位被含有芳族部分的取代基进一步取代的化合物可用于治疗受抑制TGFbeta活性改善的病症的受试者。
-
公开(公告)号:US20050096333A1
公开(公告)日:2005-05-05
申请号:US10957183
申请日:2004-09-30
申请人: Sundeep Dugar , Sarvajit Chakravarty , Alison Murphy , Glenn McEnroe , Aurelia Conte , John Perumattam
发明人: Sundeep Dugar , Sarvajit Chakravarty , Alison Murphy , Glenn McEnroe , Aurelia Conte , John Perumattam
IPC分类号: A61K20060101 , A61K31/4965 , A61K31/517 , A61K31/519 , C07D471/04 , C07D475/10 , C07D487/04
CPC分类号: C07D471/04 , C07D475/10 , C07D487/04
摘要: Quinazoline derivatives have the formula: or the pharmaceutically acceptable salts thereof; wherein each of Z5, Z6, Z7 and Z8 is N or CH and wherein one or two Z5, Z6, Z7 and Z8 are N and wherein two adjacent Z positions cannot be N; wherein m and n are each independently 0-3; wherein R1 is independently OH, SH, NH2, OR, SR, NHR, halo or R-halide; wherein two adjacent R1 groups may be joined to form an aliphatic hetero cycle ring of 5-6 members; wherein R2 is independently R, halo, R-halide, OR-halide, NH2, CONH2 or CONHR; wherein R is optionally substituted C1-C12 alkyl, C1-C12 alkenyl, C1-C12 alkynyl, or aryl C1-C12 alkyl, containing 0-4 heteroatoms in place of a carbon in the carbon backbone, where the optional substituents are ═O, ═N, or OH; and wherein R3 is H or CH3. Such compounds are useful in pharmaceutical compositions and methods of treating conditions characterized by enhanced TGFβ activity.
摘要翻译: 喹唑啉衍生物具有下式:或其药学上可接受的盐; 其中Z 5,Z 6,Z 7和Z 8各自为N或CH,其中一个或多个 两个Z 5,Z 6,Z 7和Z 8是N,并且其中两个相邻的Z位置不能是 N; 其中m和n各自独立地为0-3; 其中R 1独立地是OH,SH,NH 2,OR,SR,NHR,卤素或R卤化物; 其中两个相邻的R 1个基团可以连接形成5-6个成员的脂肪族杂环; 其中R 2独立地是R 1,R 2,R 2卤素,OR-卤素,NH 2,CONH 2或CONHR; 其中R是任选取代的C 1 -C 12烷基,C 1 -C 12 - 烯基,C
-
公开(公告)号:US07232824B2
公开(公告)日:2007-06-19
申请号:US10957183
申请日:2004-09-30
申请人: Sundeep Dugar , Sarvajit Chakravarty , Alison Murphy , Glenn McEnroe , Aurelia Conte , John J. Perumattam
发明人: Sundeep Dugar , Sarvajit Chakravarty , Alison Murphy , Glenn McEnroe , Aurelia Conte , John J. Perumattam
IPC分类号: C07D239/94 , C07D471/04
CPC分类号: C07D471/04 , C07D475/10 , C07D487/04
摘要: Quinazoline derivatives have the formula: or the pharmaceutically acceptable salts thereof; wherein each of Z5, Z6, Z7 and Z8 is N or CH and wherein one or two Z5, Z6, Z7 and Z8 are N and wherein two adjacent Z positions cannot be N; wherein m and n are each independently 0–3; wherein R1 is independently OH, SH, NH2, OR, SR, NHR, halo or R-halide; wherein two adjacent R1 groups may be joined to form an aliphatic hetero cycle ring of 5–6 members; wherein R2 is independently R, halo, R-halide, OR-halide, NH2, CONH2 or CONHR; wherein R is optionally substituted C1–C12 alkyl, C1–C12 alkenyl, C1–C12 alkynyl, or aryl C1–C12 alkyl, containing 0–4 heteroatoms in place of a carbon in the carbon backbone, where the optional substituents are ═O, ═N, or OH; and wherein R3 is H or CH3. Such compounds are useful in pharmaceutical compositions and methods of treating conditions characterized by enhanced TGFβ activity.
摘要翻译: 喹唑啉衍生物具有下式:或其药学上可接受的盐; 其中Z 5,Z 6,Z 7和Z 8各自为N或CH,并且其中一个或多个 两个Z 5,Z 6,Z 7和Z 8是N,并且其中两个相邻的Z位置不能是 N; 其中m和n各自独立地为0-3; 其中R 1独立地是OH,SH,NH 2,OR,SR,NHR,卤素或R卤化物; 其中两个相邻的R 1个基团可以连接形成5-6个成员的脂肪族杂环; 其中R 2独立地是R 1,R 2,R 2卤素,OR-卤素,NH 2,CONH 2或CONHR; 其中R是任选取代的C 1 -C 12烷基,C 1 -C 12 - 烯基,C
-
公开(公告)号:US20070293500A1
公开(公告)日:2007-12-20
申请号:US11765409
申请日:2007-06-19
申请人: Sundeep DUGAR , Sarvajit Chakravarty , Alison Murphy , Glenn McEnroe , Aurelia Conte , John Perumattam
发明人: Sundeep DUGAR , Sarvajit Chakravarty , Alison Murphy , Glenn McEnroe , Aurelia Conte , John Perumattam
IPC分类号: A61K31/519 , A61P43/00 , C07D475/00 , C07D487/04
CPC分类号: C07D471/04 , C07D475/10 , C07D487/04
摘要: Quinazoline derivatives and their pharmaceutically acceptable salts are inhibitors of TGFβ activity and are used to treat conditions characterized by enhanced TGFβ activity.
摘要翻译: 喹唑啉衍生物及其药学上可接受的盐是TGFbeta活性的抑制剂,用于治疗以增强的TGFbeta活性为特征的病症。
-
8.
公开(公告)号:US09174978B2
公开(公告)日:2015-11-03
申请号:US14665245
申请日:2015-03-23
申请人: Virender Singh Aulakh , Anthony Casarez , Xiaodong Lin , Mika Lindvall , Glenn McEnroe , Heinz Ernst Moser , Folkert Reck , Meiliana Tjandra , Robert Lowell Simmons , Aregahegn Yifru , Qingming Zhu
发明人: Virender Singh Aulakh , Anthony Casarez , Xiaodong Lin , Mika Lindvall , Glenn McEnroe , Heinz Ernst Moser , Folkert Reck , Meiliana Tjandra , Robert Lowell Simmons , Aregahegn Yifru , Qingming Zhu
IPC分类号: A61K31/40 , C07D417/14 , A61K31/427 , A61K31/454 , A61K31/4439 , A61K31/433 , A61K31/496 , A61K31/4545 , C07D487/04 , A61K45/06
CPC分类号: A61K31/427 , A61K31/433 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K45/06 , C07D417/14 , C07D487/04 , Y02A50/473 , Y02A50/481
摘要: This invention pertains generally to antibacterial compounds of Formula I, as further described herein, and pharmaceutically acceptable salts and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds to treat infections such as those caused by Gram-negative bacteria.
摘要翻译: 本发明一般涉及本文进一步描述的式I抗菌化合物及其药学上可接受的盐和制剂。 在某些方面,本发明涉及使用这些化合物治疗诸如革兰氏阴性菌引起的感染的方法。
-
公开(公告)号:US20070185112A1
公开(公告)日:2007-08-09
申请号:US11688234
申请日:2007-03-19
申请人: Babu Mavunkel , Sundeep Dugar , Gregory Luedtke , Glenn McEnroe , Xuefei Tan
发明人: Babu Mavunkel , Sundeep Dugar , Gregory Luedtke , Glenn McEnroe , Xuefei Tan
IPC分类号: A61K31/53 , A61K31/519 , A61K31/506 , A61K31/497 , A61K31/496 , C07D403/02 , C07D487/02
CPC分类号: C07D207/416 , C07D211/18 , C07D401/06 , C07D471/04 , C07D513/04
摘要: Piperazine compounds and methods for treating conditions mediated by p38-α kinase are disclosed.
摘要翻译: 公开了哌嗪化合物和治疗由p38-α激酶介导的病症的方法。
-
公开(公告)号:US06696443B2
公开(公告)日:2004-02-24
申请号:US09990184
申请日:2001-11-20
申请人: Babu Mavunkel , Sundeep Dugar , Gregory Luedtke , Xuefei Tan , Glenn McEnroe
发明人: Babu Mavunkel , Sundeep Dugar , Gregory Luedtke , Xuefei Tan , Glenn McEnroe
IPC分类号: C07D40106
CPC分类号: C07D207/416 , C07D211/18 , C07D401/06 , C07D471/04 , C07D513/04
摘要: Certain compounds which contain a piperidine moiety flanked by aryl groups are inhibitors of p38-&agr; kinase and thus useful in the treatment of a variety of conditions characterized by inappropriate p38-&agr; kinase activity.
摘要翻译: 含有侧翼为芳基的哌啶部分的某些化合物是p38-α激酶的抑制剂,因此可用于治疗以不适当的p38-α激酶活性为特征的多种病症。
-
-
-
-
-
-
-
-
-